Characteristic | Value | |
---|---|---|
Sex | 31 female / 8 male | |
Age at diagnosis (years) | 14.58 (9.49–17.84) | |
Age at evaluation (years) | 21.47 (18.05–35.71) | |
Disease duration (years) | 8.08 (1.74–23.79) | |
Years of education | 11.0 (6–17) | |
History of NPSLE | 8 (20.5%) | |
Anti dsDNA (cumulated) | 21(53.8%) | |
SLEDAI 2 K | 2.0 (0–16) | |
SLICC/ACR - DI | 0 (0–5) | |
Cumulative prednisone dose (mg) | 35.720.0(9,279.0–127,530.0) | |
Current prednisone dose (mg) | 7.5 (0–60) | |
Brazil Criterion | A2 | (5.1%) |
B1 | (7.7%) | |
B2 | (38.5%) | |
C1 | (28.2%) | |
C2 | (17.9%) | |
D | (2.6%) |